These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Influence of enoximone on myocardial energetics in patients with idiopathic dilated cardiomyopathy: comparison with nitroprusside. Hasenfuss G, Holubarsch C, Heiss HW, Meinertz T, Hofmann T, Just H. J Cardiovasc Pharmacol; 1989; 14 Suppl 1():S69-74. PubMed ID: 2480489 [Abstract] [Full Text] [Related]
3. Separation between vasodilation and positive inotropism by assessment of myocardial energetics in patients with dilated cardiomyopathy. Holubarsch C, Hasenfuss G, Allgeier M, Heiss HW, Just H. Basic Res Cardiol; 1989; 84 Suppl 1():257-65. PubMed ID: 2530975 [Abstract] [Full Text] [Related]
4. Influence of the calcium-sensitizer UDCG-115 on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy. Comparison with nitroprusside. Hasenfuss G, Holubarsch C, Heiss HW, Rattert B, Just H. Basic Res Cardiol; 1989; 84 Suppl 1():225-33. PubMed ID: 2818456 [Abstract] [Full Text] [Related]
7. Coupling between myocardial oxygen consumption and mechanics in patients with dilative cardiomyopathy. Influence of vasodilation and positive inotropism. Hasenfuss G, Holubarsch C, Heiss HW, von Herrath M, Just H. Prog Clin Biol Res; 1989 Sep; 315():613-5. PubMed ID: 2529573 [No Abstract] [Full Text] [Related]
12. Influence of enoximone and UDCG-115 on coronary hemodynamics in idiopathic dilated cardiomyopathy. Holubarsch C, Hasenfuss G, Heiss WH, Just H. Am J Cardiol; 1988 Sep 09; 62(8):104E-107E. PubMed ID: 2970783 [Abstract] [Full Text] [Related]
13. Influence of UDCG-115 on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy. Hasenfuss G, Holubarsch C, Heiss HW, Just H. Am Heart J; 1989 Sep 09; 118(3):512-9. PubMed ID: 2773772 [Abstract] [Full Text] [Related]
14. Hemodynamics and myocardial oxygen metabolism of pulsus alternans in patients with dilative cardiomyopathy. Hasenfuss G, Holubarsch C, Heiss HW, Bonzel T, Funfack M, Revenaugh M, Meinertz T, Just H. Clin Cardiol; 1987 May 09; 10(5):323-7. PubMed ID: 2954730 [Abstract] [Full Text] [Related]
15. Comparative effects on hemodynamics of enoximone (MDL 17,043), dobutamine and nitroprusside in severe congestive heart failure. Installé E, Gonzalez M, Jacquemart JL, Collard P, Roulette F, Pourbaix S, Tremouroux J. Am J Cardiol; 1987 Aug 14; 60(5):46C-52C. PubMed ID: 2956868 [Abstract] [Full Text] [Related]
16. The effect of the partial beta-1-adrenoceptor agonist xamoterol on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy. Thierfelder L, Holubarsch C, Hasenfuss G, Heiss HW, Just H. J Cardiovasc Pharmacol; 1991 Apr 14; 17(4):593-9. PubMed ID: 1711626 [Abstract] [Full Text] [Related]
17. Diastolic function in patients with severe heart failure: comparison of the effects of enoximone and nitroprusside. Herrmann HC, Ruddy TD, Dec GW, Strauss HW, Boucher CA, Fifer MA. Circulation; 1987 Jun 14; 75(6):1214-21. PubMed ID: 2952373 [Abstract] [Full Text] [Related]
18. Inotropic effect of enoximone in patients with severe heart failure: demonstration by left ventricular end-systolic pressure-volume analysis. Herrmann HC, Ruddy TD, William G, Strauss HW, Boucher CA, Fifer MA. J Am Coll Cardiol; 1987 May 14; 9(5):1117-23. PubMed ID: 2952702 [Abstract] [Full Text] [Related]
19. Hemodynamic effects of MDL 17,043, a new cardiotonic agent, in patients with congestive heart failure: comparison with sodium nitroprusside. Arbogast R, Brandt C, Haegele KD, Fincker JL, Schechter PJ. J Cardiovasc Pharmacol; 1983 May 14; 5(6):998-1004. PubMed ID: 6196573 [Abstract] [Full Text] [Related]
20. Peripheral and cardiac effects of a new phosphodiesterase inhibitor in comparison with enoximone. Schröder T, Hering JP, Foth H, Ferrari M, Sipinková I, Hellige G. Arzneimittelforschung; 1994 Aug 14; 44(8):948-50. PubMed ID: 7945538 [Abstract] [Full Text] [Related] Page: [Next] [New Search]